These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35970423)

  • 1. Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Lee CM; Johns SL; Stulberg DB; Allen RH; Janiak E
    Contraception; 2023 Jan; 117():39-44. PubMed ID: 35970423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB
    Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.
    Wagner MS; Munro S; Wilcox ES; Devane C; Norman WV; Dunn S; Soon JA; Guilbert É
    J Obstet Gynaecol Can; 2020 May; 42(5):576-582. PubMed ID: 31924442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    LaRoche KJ; Wynn LL; Foster AM
    Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Carvajal D; Logan R; Dehlendorf C
    Contraception; 2022 May; 109():19-24. PubMed ID: 35131289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Srinivasulu S; Yavari R; Brubaker L; Riker L; Prine L; Rubin SE
    Contraception; 2021 Jul; 104(1):92-97. PubMed ID: 33910031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
    Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S
    Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Holt K; Fox E; Silverstein I; Dehlendorf C
    J Am Board Fam Med; 2022; 35(3):579-587. PubMed ID: 35641055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA.
    Neill S; Mokashi M; Goldberg A; Fortin J; Janiak E
    Perspect Sex Reprod Health; 2023 Sep; 55(3):210-217. PubMed ID: 37394759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
    Neill S; Hoe E; Fortin J; Goldberg AB; Janiak E
    Contraception; 2023 Oct; 126():110108. PubMed ID: 37394110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.
    Raifman S; Gurazada T; Beaman J; Biggs MA; Schwarz EB; Gold M; Grossman D
    BMC Womens Health; 2024 Jul; 24(1):382. PubMed ID: 38956609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.
    Devane C; Renner RM; Munro S; Guilbert É; Dunn S; Wagner MS; Norman WV
    Pilot Feasibility Stud; 2019; 5():126. PubMed ID: 31720004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
    Sakthivel M; Wolff H; Monast K; McHugh A; Stulberg D; Janiak E
    Contraception; 2024 Feb; 130():110280. PubMed ID: 37704043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
    Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
    Contraception; 2023 May; 121():109962. PubMed ID: 36736715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
    Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA
    Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has mifepristone medical abortion expanded abortion access in New Mexico? A survey of OB-GYN and Family Medicine physicians.
    Espey E; Leeman L; Ogburn T; Skipper B; Eyman C; North M
    Contraception; 2011 Aug; 84(2):178-83. PubMed ID: 21757060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Calloway D; Stulberg DB; Janiak E
    Contraception; 2021 Jul; 104(1):24-28. PubMed ID: 33891965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health workers' experience of providing second-trimester abortion care in Ethiopia: a qualitative study.
    McLean E; Blystad A; Mirkuzie AH; Miljeteig I
    Reprod Health; 2023 Oct; 20(1):154. PubMed ID: 37848942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.